Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Altimmune, Inc. (ALT) had Cash Flow from Financial Activities of $78.47M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-22.56M |
|
-- |
|
-- |
|
$24.24M |
|
$-24.24M |
|
$1.68M |
|
$-22.56M |
|
$-22.56M |
|
$-22.56M |
|
$-22.56M |
|
$-22.56M |
|
$-22.56M |
|
$-24.24M |
|
$-24.87M |
|
124.46M |
|
124.46M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$334.68M |
|
$0.21M |
|
$0.95M |
|
$335.63M |
|
$11.32M |
|
$34.51M |
|
$40.32M |
|
$51.64M |
|
$283.99M |
|
$283.99M |
|
$283.99M |
|
130.22M |
|
| Cash Flow Statement Financials | |
$-20.94M |
|
$-3.69M |
|
|
Cash Flow from Financial Activities |
$78.47M |
$43.80M |
|
$97.64M |
|
$53.84M |
|
$3.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
29.56 |
|
-- |
|
-- |
|
0.11 |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.95% |
|
-7.95% |
|
-6.72% |
|
-7.08% |
|
$2.18 |
|
$-0.17 |
|
$-0.17 |
|